Dementia

A practical approach to cognitive impairment management

Important developments in dementia: biomarkers & clinical trials

Targeting β-amyloid and tau in Alzheimer’s disease

The importance of joint prevention programs for dementia, stroke and heart disease

The validity of the amyloid cascade hypothesis of Alzheimer’s disease

Should findings from monogenic dementias inform sporadic disease research?

The role of β-amyloid in AD: still a central characteristic?

Are viruses a major cause of amyloid deposition in Alzheimer’s disease?

Non-pharmacological interventions to prevent dementia progression

Financial capacity assessment in dementia patients: a new prediction tool for disease progression?

Early diagnosis & genetic risk in Alzheimer’s disease

What happens to the blood-brain barrier in neurodegenerative disease?

Blood-brain barrier dysfunction in cognitive decline: cause or bystander?

Selective neuronal vulnerability in neurodegenerative diseases

Herpes simplex virus and Alzheimer’s disease

Visualizing blood-brain barrier dysfunction as an early marker of neurodegeneration